Summary.-The dose-response relationships from the data described in Paper I were analysed. Among unpromoted animals, only doses sufficient to cause ulceration with subsequent promotion due to wound healing caused a rapid crop of tumours, so the dose-response curve exhibited strong upward curvature. Among promoted animals, the response of the skin to initiation appeared to have been nearly saturated by all DMBA doses tested, so that a 30-fold decrease in dose produced only a 3-fold decrease in effect. The dose-response relationship thus exhibited strong downward curvature.
The siynificance ofdowvnward curvature.
The study of dose-response relationships is of interest for two reasons. First, the nature of the dose-response relationship may shed some light on the biological processes involved in carcinogenesis. For example, some hypotheses about cancer mechanisms predict an approximately linear dose response (i.e. proportionality between dose and number of tumours) while most others predict some upward curvature in the dose-response graph (i.e. that doubling the dose would more than double the effect). If downward curvature were demonstrated, this would exclude a large class of previously plausible hypotheses.
Second, because of the need to promulgate government regulations for various carcinogens, there is currently much dispute as to the magnitude of the risk likely to be associated with human exposure to lower doses of various carcinogens than can be studied in practicable experimental or epidemiological investigations. Some authors (e.g. Guess et al., 1977; Crump et al., 1976; Peto, 1979) have urged that a clear distinction be made between "oneshot" experiments (in which the effects of a single, usually toxic dose of carcinogen are studied) and "continuous" experiments (studying the effects of repeated doses, each insufficient separately or together to alter materially the cellular architecture of the target tissue). Mantel & Schneiderman, 1975, or Cornfield, 1977) (a) the relationship between initiating dose and the response to promotion, when promotion does eventually occur, and (b) the relationship between initiating dose and the number of tumours that arise soon after initiation in the absence of TPA promotion (due, perhaps, to the promotional effects of the healing of the ulcers and erosions caused by some DMBA doses).
In each case we may assess response by any 1 of 4 different indices of cancer incidence, .e.
(i) the total nunmber of tumours arising within a particular 20-week period of time (to which one mouse may contribute more than one tumour, which makes the calculation of reliable P values difficult), or (ii-iv) the number of tumour-bearing animals, i.e. by a standard time-to-first-tumour analysis, with P values, of (ii) any tumour, irrespective of size or type, or (iii) 10mm tumours, or (iv) malignant tumours.
Details of the experimental and statistical methods are given in the accompanying paper by Stenbiack et al. (1981) .
RESULTS
The dependence on initiating dose of the effects of promotion No matter which index of response is adopted (small tumours, large tumours or malignant tumours), Fig. 1 What is perhaps more interesting is the finding that the number of 10mm tumours arising 9-12 months after uinpromoted initiation should exhibit the same discontinuity. This suggests that early promotion, either by woun(l healing or by TPA, can irreversibly "fix" certain cells (or microscopic clones of cells) in a higher risk category. In multistage terminology, this might be described as progression to a later "stage" of neoplastic development).
If there is indeed an irreversible cellular effect which can be produced by brief promotion, the simple dichotomy between normal cells and initiated cells will need to be extended to allow various categories of initiated cells (or microscopic clones of cells), and promotion itself may prove to be a multi-step process, as was suggested by Boutwell (1964) and Slaga et al. (1980) . Initiation w)ith promotion
The downward curvature of the doseresponse curve indicates that the generalizations about "conservative" risk estimation by linear extrapolation which have been proposed for continuous-carcinogenesis experiments cannot necessarily be carried over to single-dose experiments. This emphasizes the particular need to check the assumptions of linearity underlying the setting of safety levels for radiation exposure, since so much radiation data come from single-dose studies.
The reasons for such a dose-response relationship in the present context are unclear, especially since for another polyaromatic hydrocarbon, benzo(a)pyrene, Pereira et al. (1979) have shown simple proportionality between the dose applied to mouse skin and the amount subsequently bound to the epidermal DNA. One possible explanation is that even our lowest dose (20-50 tZg/cm2) sufficed to initiate nearly all the available target cells, and another is that higher doses actually kill off many of the initiated cells. Both are made plausible by other observations. Mondal & Heidelberger (1970) have shown in vitro that they can "transform" most of a population of cultured mammalian cells with MCA, and and have shown in vitro that they can "initiate" most of a population of cultured mammalian cells with an X-ray dose of 100 rad. Major & Mole (1978) have shown that if mice irradiated with 100 rad are randomized between getting and avoiding a further such dose of X-rays, those which get a further dose are less likely to develop leukaemia, presumably because the second dose kills more preleukaemic cells than it generates. Finally, returning to DMBA on mouse skin, it has been shown that 100 doses of 1 jtg of DMBA, given twice weekly are nmuch more tumorigenic than a single dose of 100 jig (Saffiotti & Shubik, 1956 ), which again is what would be expected if small doses suffice to initiate almost all the cells which are temporarily at risk of initiation.
In retrospect, since we believe that we did saturate the possible response of the mouse skin, we do not recommend that future workers treat such a small area of the back of the mouse as we did. Using a volume of solvent sufficient to spread over the whole shaved back, at dose levels per unit area which are sufficiently low not to saturate the possible response of the skin, (i) will avoid any complication due to promotional wound healing;
(ii) will allow any factors modifying the efficacy of DMBA to be measured; and (iii) will cause more target cells to be exposed, which will improve the statistical accuracy of the results.
If such doses do not produce high enough tumour yields, it would perhaps be better to study initiation by a few weekly very low doses rather than by single substantial doses. 
